
The Curbsiders Internal Medicine Podcast #420 Recap Extravaganza: 2023 Highlights and Top Stories
4 snips
Dec 25, 2023 The podcast covers a range of interesting topics including menopause therapy, hemochromatosis, hematuria management, diabetes updates, xylazine overdose and withdrawal, primary aldosteronism, resistant hypertension, delirium, AKI risk, statin therapy in HIV patients, inpatient heart failure management, kratom use implications, and effectiveness of RSV vaccines.
AI Snips
Chapters
Transcript
Episode notes
Practical Tips For Insulin Use
- Use NPH as an affordable basal insulin option (two-thirds morning, one-third evening) and consider splitting degludec at low doses.
- Watch for over‑basalization; add prandial insulin if basal exceeds ~0.5 U/kg.
Xylazine Creates Naloxone‑Resistant Overdoses
- Xylazine (tranq) is an alpha-2 agonist in the illicit supply that causes naloxone-resistant overdoses and unique wounds.
- No rapid hospital test or reversal agent exists, complicating management and recognition.
Test Early For Primary Aldosteronism
- Screen for primary aldosteronism in resistant hypertension; test with morning renin and aldosterone levels.
- Low renin while on typical meds (ACE/ARB, diuretic, CCB) is a strong clue to primary aldosteronism.
